We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Oncologist Support for Euthanasia Declines

By HospiMedica staff writers
Posted on 10 Oct 2000
A survey of 3,299 oncologists has revealed that the support for euthanasia and physician-assisted suicide of terminally ill cancer patients has dramatically declined in recent years. More...
The survey also found that oncologists who had been trained in end-of-life care were less likely to support or carry out euthanasia or physician-assisted suicide. The researchers who conducted the survey say this may reflect an improved ability by some oncologists to provide appropriate care for their dying patients.

A study that compared the results of this survey, conducted in 1998, with a survey conducted in 1994 showed that support for euthanasia for dying cancer patients in excruciating pain has dropped from 23% in 1994 to 7% in 1998. Similarly, support for physician-assisted suicide for terminally ill cancer patients with unremitting pain has dropped from 45% to 22%. The study results were published in the October 3 issue of the Annals of Internal Medicine.

In the recent survey, nearly one-third of the oncologists who participated said they would be reluctant to increase the dosage of morphine for a dying cancer patient in excruciating pain. This reticence to relive pain appears to reflect physician fears that increasing the dose of morphine may also raise a patient's risk of respiratory depression and death, which might be construed as euthanasia. The participants in the survey were members of the American Society of Clinical Oncology (ASCO).

These study results underscore the need for physician education of optimal pain and palliative care practices, said Robert J. Mayer, M.D., professor of medicine at Harvard Medical School and leader of the study. Physicians who are better informed about end-of-life issues feel less need to use euthanasia and physician-assisted suicide.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.